Drug Profile
Olanzapine - INVENT Pharmaceuticals
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator INVENT Pharmaceuticals
- Class Antidepressants; Antiemetics; Antimanics; Antipsychotics; Behavioural disorder therapies; Benzodiazepines; Mood stabilisers; Oxazepines; Small molecules; Thiazepines
- Mechanism of Action Dopamine D1 receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Psychotic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Psychotic-disorders(In volunteers) in Spain (PO, Tablet)